Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • News
  • Trading Ideas

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,600 Today

By Benzinga Insights
June 18, 2:30 PM
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 10 years by 11.41% on an annualized basis…

IDXX

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

How Is The Market Feeling About IDEXX Laboratories?

By Benzinga Insights
June 13, 10:45 AM
IDEXX Laboratories’s (NYSE:IDXX) short percent of float has risen 3.44% since its last report. The company recently reported…

IDXX

Read More
1 minute read
  • News
  • Trading Ideas

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,500 Today

By Benzinga Insights
May 30, 4:00 PM
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 20 years by 2.72% on an annualized basis…

IDXX

Read More
1 minute read
  • News
  • Trading Ideas

$100 Invested In This Stock 15 Years Ago Would Be Worth $2,500 Today

By Benzinga Insights
May 20, 3:00 PM
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 11.59% on an annualized basis…

IDXX

Read More
1 minute read
  • Broad U.S. Equity ETFs
  • Econ #s
  • Equities
  • ETFs
  • Large Cap
  • Macro Notification
  • Market Summary
  • Markets
  • Real Estate
  • Top Stories

S&P 500, Nasdaq 100, Dow Jones Shatter Record Highs In Unstoppable Bull Market Rally

By Piero Cingari
May 15, 4:18 PM
The S&P 500, Nasdaq 100 and Dow Jones Industrial Average indices all shattered fresh all-time highs Wednesday, driven by a benign inflation report that boosted risk sentiment among bullish investors.

AMGN

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Top Stories
  • Trading Ideas

Aging Pet Population Is ‘Solid Longer-Term Tailwind’ For IDEXX Labs: Analyst

By Vandana Singh
May 1, 3:27 PM
IDEXX Laboratories reports Q1 EPS of $2.81 (up 10% Y/Y), with sales reaching $964M (7% increase). Revenue growth driven by Companion Animal Group and Water segments. Operating margin at 31.0%. 2024 revenue forecasted at $3.895-$3.965 billion.

IDXX

Read More
1 minute read
  • News
  • Trading Ideas

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,200 Today

By Benzinga Insights
April 26, 5:30 PM
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 5 years by 5.0% on an annualized basis…

IDXX

Read More
1 minute read
  • News
  • Trading Ideas

$1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth This Much Today

By Benzinga Insights
April 16, 3:00 PM
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 10 years by 13.2% on an annualized basis…

IDXX

Read More
2 minute read
  • Equities
  • General
  • Health Care
  • Management
  • News

Investor Activism: Elanco Animal Health Settles with Ancora, Adds New Board Members

By Vandana Singh
April 1, 8:45 AM
Elanco Animal Health settles with Ancora, expanding board to 14 members, including Ancora's nominees Craig Wallace and Kathy Turner. Ancora's significant stake in Elanco, approximately $250 million, has driven discussions on board restructuring and CEO succession planning.

ELAN

Read More
1 minute read
  • News
  • Trading Ideas

Here’s How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years

By Benzinga Insights
March 27, 2:30 PM
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 20 years by 3.81% on an annualized basis…

IDXX

Posts pagination

1 2 … 8 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service